MEREO BIOPHARMA GROUP PLC Adjustments For Decrease Increase In Trade Account Receivable
MEREO BIOPHARMA GROUP PLC (MREO) reported Adjustments For Decrease Increase In Trade Account Receivable of GBP 804.31 thousand for the 12-month period ending 2018-12-31, per its 20-F/A filed 2019-05-29.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2019-05-29
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|
| 2018-12-31 | 804.31K GBP 20-F/A · filed 2019-05-29 |
| 2017-12-31 | -839.75K GBP 20-F/A · filed 2019-05-29 |
| 2016-12-31 | -1.22M GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |